SPAVENTA ANDREW (Chief Executive Officer) reported 2 transactions at SINGULAR GENOMICS SYSTEMS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/24/2022ACC: 0001209191-22-021034
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
-163.38K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
9.77K acquired · 173.14K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−173.14K
Price / share
—
Trade value
—
% of position
New position
3/24/2022
173.14K→0.00
Common Stock
Direct
Shares
+9.77K
Price / share
—
Trade value
—
% of position
New position
3/24/2022
0.00→9.77K
Total
Net shares
−163.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/24/2022 | J · J | −173.14K | — | — | New position | 173.14K | 0.00 |
| Common Stock Direct | 3/24/2022 | J · J | +9.77K | — | — | New position | 0.00 | 9.77K |
| Total | −163.38K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.41M
Total
4.41M indirect4.41M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.41M | Indirect |
| Total | 4.41M | 4.41M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported